Research Overview: PEPTIDES Tirzepatide (Tirzepatide GIP and GLP-1 Receptor Agonist) IN VIALS Deus Medical
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, engineered for advanced metabolic research applications. This synthetic peptide demonstrates unique pharmacological properties through its dual incretin receptor activation mechanism, making it a valuable tool for investigating glucose homeostasis and energy metabolism pathways in laboratory settings. Researchers examining metabolic disorders, insulin sensitivity, and incretin biology will find this compound particularly useful for in-vitro studies. The dual receptor approach distinguishes tirzepatide from single-pathway modulators, offering researchers opportunities to study complex metabolic interactions. Stroid UK Shop provides this research-grade peptide with verified purity for consistent experimental results.
Laboratory Applications
Research scientists utilise tirzepatide to investigate dual incretin receptor signalling pathways and their effects on glucose-dependent insulin secretion. The compound’s ability to activate both GIP and GLP-1 receptors simultaneously makes it valuable for studying metabolic regulation mechanisms in cell culture models. Laboratories examining pancreatic beta-cell function, hepatic glucose production, and gastric motility find this peptide essential for understanding complex metabolic processes. The research applications extend to studying incretin hormone interactions with various metabolic tissues. Scientists working with metabolic research peptides appreciate the compound’s well-characterised receptor binding profile and its potential for investigating novel therapeutic pathways in metabolic dysfunction models.
Research Specifications
| Parameter | Specification |
|---|---|
| Chemical Name | Tirzepatide (dual GIP/GLP-1 receptor agonist) |
| Molecular Formula | Verify with supplier |
| CAS Number | Verify with supplier |
| Molecular Weight | Verify with supplier |
| Purity | Research grade |
| Form | Lyophilised powder in vials |
| Storage | -20°C for lyophilised form |
| Manufacturer | Deus Medical |
The peptide arrives as a sterile lyophilised powder requiring reconstitution with appropriate research-grade solvents. Researchers studying research peptides should follow established protocols for peptide handling and storage to maintain compound integrity. The dual receptor mechanism requires careful consideration when designing experimental protocols, as both GIP and GLP-1 pathways contribute to the observed effects in metabolic studies.
Research Compliance
This tirzepatide preparation is manufactured exclusively for laboratory research applications and in-vitro studies. The compound is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must ensure proper laboratory protocols, safety measures, and regulatory compliance when handling this peptide. Studies involving research compounds require appropriate institutional oversight and adherence to relevant safety guidelines. All research activities must comply with local regulations governing peptide research and laboratory safety standards, with particular attention to proper storage, handling, and disposal procedures for research-grade peptides.
